| Weeks After Starting | Weeks After Stopping | ALT (U/L) | Alk P (U/L) | Bilirubin (mg/dL) | Other |
|---|---|---|---|---|---|
| 0 | Leflunomide (20 mg daily) started | ||||
| 8 | 0 | 30 | 95 | 0.6 | |
| 12 | 0 | Leflunomide stopped, hydroxychloroquine started | |||
| 16 | 4 | 121 | 632 | 9.8 | CT Scan |
| 17 | 5 | 98 | 500 | 9.3 | |
| 18 | 6 | 106 | 575 | 6.5 | ERCP |
| 21 | 9 | 86 | 704 | 3.3 | |
| 26 | 14 | 67 | 545 | 1.4 | |
| 30 | 18 | 65 | 520 | 1.0 | |
| 32 | 20 | 52 | 414 | 0.8 | |
| 40 | 28 | 45 | 185 | 0.6 | |
| 48 | 36 | 66 | 291 | 0.5 | |
| 52 | 40 | 41 | 263 | 0.3 | |
| 58 | 48 | 35 | 170 | 0.4 | |
| 58 | Hydroxychloroquine restarted | ||||
| 62 | 24 | 110 | 0.4 | ||
| 86 | 29 | 103 | 0.5 | ||
| Normal Values | <40 | <115 | <1.2 | ||
From: Leflunomide
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.